1,115 results on '"Ylstra, Bauke"'
Search Results
2. Prognostic Value of T-Cell Density in the Tumor Center and Outer Margins in Gastric Cancer
3. Multi-scale spatial modeling of immune cell distributions enables survival prediction in primary central nervous system lymphoma
4. Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer
5. Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma
6. Hidden RNA profiles of cells in the tumor microenvironment accurately revealed by malignant cell fraction-informed deconvolution
7. Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials
8. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
9. Microsatellite instability and sex differences in resectable gastric cancer – A pooled analysis of three European cohorts
10. A bioinformatics perspective on molecular classification of diffuse large B-cell lymphoma
11. A multi-platform reference for somatic structural variation detection
12. Molecular pathways in post-colonoscopy versus detected colorectal cancers: results from a nested case–control study
13. Molecular characterization of colorectal cancer related peritoneal metastatic disease
14. Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling
15. Table S1 from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen
16. Supp Figures from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen
17. Supplemental Figures Legends from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen
18. Data from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen
19. Supplementary Appendix from The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen
20. The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen
21. Chromosome 20 loss is characteristic of breast implant–associated anaplastic large cell lymphoma
22. Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of Glioblastoma
23. Expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer
24. Two types of primary mucinous ovarian tumors can be distinguished based on their origin
25. The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen
26. Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: relation to grade, histopathology and overall survival in the GLASS-NL cohort
27. Spatiotemporal regulation of clonogenicity in colorectal cancer xenografts
28. Chromosomal copy number heterogeneity predicts survival rates across cancers
29. Bayesian log-normal deconvolution for enhanced in silico microdissection of bulk gene expression data
30. Robust detection of translocations in lymphoma FFPE samples using targeted locus capture-based sequencing
31. Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment
32. DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly.
33. The Impact of Genetic Subtypes of Diffuse Large B-Cell Lymphoma for Outcome Prediction and Interpretation of FDG-PET treatment Response Monitoring
34. Clonal Patterns Between Pouch Neoplasia and Prior Colorectal Neoplasia in Inflammatory Bowel Disease Patients: An Exploratory Cohort Study
35. Supplementary Tables from Large B-cell Lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B Cell
36. DNA or RNA? Classification of B-cell lymphomas
37. Data from Large B-cell Lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B Cell
38. Supplementary Data from Large B-cell Lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B Cell
39. Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer
40. Breast tumor copy number aberration phenotypes and genomic instability
41. IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas
42. Copy number signatures and mutational processes in ovarian carcinoma
43. Table S2 from Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining
44. Figure S3 from Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining
45. Data from Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining
46. Supplementary Table S3 from Microarray Analysis of Bleomycin-Exposed Lymphoblastoid Cells for Identifying Cancer Susceptibility Genes
47. Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment
48. Supplementary Table 1 from Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies
49. Supplementary Table 1 from Breast Cancers with a BRCA1-like DNA Copy Number Profile Recur Less Often Than Expected after High-Dose Alkylating Chemotherapy
50. Supplementary Figure 2 from Chromosome 5q Loss in Colorectal Flat Adenomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.